Not applicableStudy completedNCT04663503What this trial is testingBenefits of Exercise Program in Pediatric HSCTWho this might be right forExerciseTransplantation Phoenix Children's Hospital 40
Not applicableUnknownNCT05609227What this trial is testingEffect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell TransplantationWho this might be right forHematologic MalignancyPatient Education Baskent University 36
Testing effectiveness (Phase 2)Looking for participantsNCT03219359What this trial is testingAutologous Stem Cell Transplant for Crohn's DiseaseWho this might be right forCrohn Disease Aaron Etra 50
Testing effectiveness (Phase 2)Study completedNCT00006390What this trial is testingAlemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group
Not applicableStudy completedNCT05315882What this trial is testingCytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERAWho this might be right forCMV Infection Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300
Not applicableNot Yet RecruitingNCT07552480What this trial is testingClinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using GoserelinWho this might be right forAllogeneic Haematopoietic Stem Cell TransplantationMalignant Hematologic DiseaseOvarian Insufficiency Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 64
Testing effectiveness (Phase 2)Study completedNCT01323920What this trial is testingBortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related DonorsWho this might be right forLeukemiaLymphomaMyelodysplastic Syndrome Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT00003942What this trial is testingGene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's LymphomaWho this might be right forLymphoma Systemix 15
Early research (Phase 1)Study completedNCT00968162What this trial is testingSickle Cell Disease Conditioning for Bone Marrow TransplantWho this might be right forBone Marrow TransplantationSickle Cell Disease Emory University 8
Not applicableStudy completedNCT07116018What this trial is testingPsychoeducation for AlloHCT CaregiversWho this might be right forCancerCaregiversStem Cell Transplant+2 more University Health Network, Toronto 17
Testing effectiveness (Phase 2)Ended earlyNCT03298412What this trial is testingEffect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)Who this might be right forHigh-risk Diffuse Large B-cell Lymphoma Amgen 10
Post-approval studies (Phase 4)Study completedNCT05087212What this trial is testingMobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma PatientsWho this might be right forAutologous Haematopoietic Stem Cell Transplant Sanofi 53
Testing effectiveness (Phase 2)Study completedNCT01525407What this trial is testingDonor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell TransplantationWho this might be right forMalignant Neoplasm Fred Hutchinson Cancer Center 83
Testing effectiveness (Phase 2)Study completedNCT00024466What this trial is testingChemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953What this trial is testingSafety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT) Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Early research (Phase 1)Study completedNCT01300572What this trial is testingYttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSWho this might be right forChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic Leukemia+3 more Fred Hutchinson Cancer Center 16
Not applicableStudy completedNCT02033928What this trial is testingComprehensive Frailty AssessmentWho this might be right forMyeloma, MultipleParaproteinemiasHematologic Neoplasms Ohio State University Comprehensive Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT02250300What this trial is testingMLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic TransplantationWho this might be right forAllogeneic Hematopoietic Stem Cell Transplantation Mehdi Hamadani 68
Early research (Phase 1)Not Yet RecruitingNCT06900192What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple SclerosisWho this might be right forPrimary Progressive Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Primary Progressive+1 more Stanford University 10